• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses

    3/2/26 9:30:00 AM ET
    $GV
    Other Consumer Services
    Real Estate
    Get the next $GV alert in real time by email

    HONG KONG, March 02, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ:GV) ("the Company"), a technology-driven multinational and biotechnology and healthcare-focused company, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited ("GV Hong Kong"), today announced the signing of a US$12 million exclusive distribution agreement for its flagship anti-aging product, Premier Regenerative Complex---President Super Injection, in cooperation with Huajin China Investment Company("Huajin China"), alongside the Board-approved divestiture of its non-core education business.

    These strategic actions mark the Company's formal transition into a commercialization acceleration phase within the high-end medical aesthetics sector.

    Commercialization Milestone for Premier Regenerative Complex – President Super Injection

    The Company's wholly owned subsidiary, Visionary Health Technology Group Limited, has entered into an exclusive distribution agreement with Huajin China, establishing a minimum contracted sales target of US$12 million within a 12-month period. Revenue recognition will be subject to product delivery, customer acceptance, and applicable accounting standards.

    This agreement represents a significant step in scaling the commercial deployment of Premier Regenerative Complex – President Super Injection, reflecting growing market acceptance and strengthening revenue visibility.

    Strategic Divestiture to Concentrate on Core Medical Aesthetics Track

    On February 27, 2026, the Company's Board of Directors approved the transfer of 100% equity interests in Visionary Education Services & Management Inc., completing the planned exit from non-core legacy operations.

    With this divestiture, Visionary Holdings will operate as a streamlined biotechnology and healthcare-focused enterprise, allocating capital, technology and management resources exclusively toward:

    • Anti-aging injectable products
    • Regenerative medical aesthetics
    • Biotechnology-driven healthcare innovation

    The product is intended for aesthetic and wellness applications and is not intended to diagnose, treat, cure, or prevent any disease.

    Management Commentary

    Xiyong Hou, Chief Executive Officer of Visionary Holdings, commented:

    "With the completion of our core business refocusing and asset structure optimization, the Company is formally entering a more focused and execution-driven growth phase within the global medical aesthetics market.

    Over the past several years, we have undertaken extensive strategic evaluation and operational refinement to identify the most scalable and value-accretive direction for Visionary Holdings. Through disciplined analysis and market validation, we have established medical aesthetics and regenerative injectable products as our long-term core growth engine.

    The signing of this exclusive distribution agreement for Premier Regenerative Complex – President Super Injection™ represents not only a significant commercialization milestone, but also the beginning of a new execution-centered growth cycle. At the same time, the divestiture of our non-core education assets materially enhances our capital efficiency and strengthens our financial flexibility.

    By concentrating resources on high-margin, high-growth medical aesthetics and biotechnology-driven healthcare innovation, we believe the Company is entering a structured growth cycle characterized by improved revenue visibility, stronger operational focus, and enhanced financial capacity to support sustainable expansion."

    About Huajin China Investment Company

    Huajin China is an industry-focused operating platform dedicated to community-based smart elderly care and senior health management. The Company has established more than 900 health and wellness chain centers across over 20 provinces in China, forming an integrated "offline service network + digital management system + health product supply chain" operating model. Leveraging a light-asset franchise structure and standardized replication capabilities, Huajin has strategically expanded into China's county-level elderly care markets while advancing the digital transformation of smart home-based senior care services. Looking ahead, the Company aims to drive industry consolidation and capital market integration to become a leading AI-driven digital elderly care platform in the Asia-Pacific region.

    About Visionary Holdings Inc.

    Visionary Holdings Inc. (NASDAQ:GV) is a technology-driven multinational enterprise focused on innovative education, AI applications, and high-tech healthcare solutions. Headquartered in Toronto, Canada, the Company operates through its subsidiaries across North America and Asia, driving technological advancement, cross-border innovation, and global health transformation.

    Cautionary Note Regarding Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will", "expects", "anticipates", "future", "intends", "plans", "believes", "estimates", "target", "going forward", "outlook," "objective" and similar terms. Such statements are based upon management's current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and which are beyond GV's control, which may cause GV's actual results, performance or achievements (including the RMB/USD value of its anticipated benefit to GV as described herein) to differ materially and in an adverse manner from anticipated results contained or implied in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in GV's filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov. GV does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

    Contacts:

    Visionary Holdings Inc.

    Investor Relations

    Email: [email protected]



    Get the next $GV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GV

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses

    HONG KONG, March 02, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ:GV) ("the Company"), a technology-driven multinational and biotechnology and healthcare-focused company, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited ("GV Hong Kong"), today announced the signing of a US$12 million exclusive distribution agreement for its flagship anti-aging product, Premier Regenerative Complex---President Super Injection, in cooperation with Huajin China Investment Company("Huajin China"), alongside the Board-approved divestiture of its non-core education business. These strategic actions mark the Company's formal transition into a commercializati

    3/2/26 9:30:00 AM ET
    $GV
    Other Consumer Services
    Real Estate

    Visionary Holdings Announces Continued Progress of Approximately US$9 Million Sales Contract

    HONG KONG, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ:GV) ("the Company"), a technology-driven multinational enterprise, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited ("GV Hong Kong"), continued execution progress under its previously signed commercial sales agreement with a total contract value of approximately US$9 million. The agreement, signed in September 2025, is currently in the implementation stage, with service activities underway. GV Hong Kong is working closely with its business partner to advance phased implementation efforts under the terms of the agreement. Execution UpdateSince the signing of the agreemen

    2/24/26 9:50:00 AM ET
    $GV
    Other Consumer Services
    Real Estate

    Visionary Holdings (Nasdaq: GV) Establishes Three Wholly Owned Subsidiaries in Qingdao, Wuxi and Wuhu, Advancing Commercial Expansion in China

    HONG KONG, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. ("GV" or the "Company") (NASDAQ:GV), a technology-driven multinational enterprise, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited, has established three new regional wholly owned subsidiaries in Qingdao, Wuxi and Wuhu, China. These subsidiaries are primarily dedicated to localized market expansion, institutional partnerships, and frontline sales execution for GV's regenerative medicine, cellular rejuvenation, and aesthetic treatment product portfolio. This development represents a meaningful operational milestone in GV's transition from strategic platform buildout to coordina

    2/18/26 9:31:00 AM ET
    $GV
    Other Consumer Services
    Real Estate

    $GV
    SEC Filings

    View All

    SEC Form 6-K filed by Visionary Holdings Inc.

    6-K - Visionary Holdings Inc. (0001892274) (Filer)

    1/28/26 3:59:25 PM ET
    $GV
    Other Consumer Services
    Real Estate

    SEC Form 20-F filed by Visionary Holdings Inc.

    20-F - Visionary Holdings Inc. (0001892274) (Filer)

    1/28/26 3:09:49 PM ET
    $GV
    Other Consumer Services
    Real Estate

    SEC Form 6-K filed by Visionary Holdings Inc.

    6-K - Visionary Holdings Inc. (0001892274) (Filer)

    5/7/25 4:10:23 PM ET
    $GV
    Other Consumer Services
    Real Estate

    $GV
    Financials

    Live finance-specific insights

    View All

    GV Innovative High-Value Business Model and Diversified Development Strategy

    TORONTO, May 24, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ:GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in Canada and market partners in China, today announced the Company's innovative high-value business model and diversified development strategy are estimated to yield returns several times over for short, medium, and long-term investors in the Nasdaq market. The Company is recognized for its innovative high-value niche market transformation strategy, which aims to achieve substantial corporate profitability and growth. Renowned for its global forward-looking professional pers

    5/24/24 8:35:00 AM ET
    $GV
    Other Consumer Services
    Real Estate

    $GV
    Leadership Updates

    Live Leadership Updates

    View All

    Visionary Holdings (Nasdaq: GV) Appoints CEO of Health Technology Business, Establishes New Sales Entity in Nanjing to Accelerate Commercial Execution in China Market

    HONG KONG, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (NASDAQ:GV), today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited("GV Hong Kong"), has official appointed Ms. Wenxuan Cai as Chief Executive Officer of GV Hong Kong, effective immediately. In parallel, the GV Hong Kong has established a new wholly owned subsidiary in Nanjing, China, dedicated primarily to sales execution and market development. This milestone marks GV's formal transition from strategic positioning to active on-the-ground revenue generation. Strengthening Leadership to Drive Marke

    12/30/25 9:30:00 AM ET
    $GV
    Other Consumer Services
    Real Estate

    Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development

    TORONTO, Nov. 4, 2025 /PRNewswire/ -- At 10:00 a.m. (Eastern Time, USA) on November 3, 2025, Visionary Holdings Inc. ((hereinafter referred to as the ", Company", , NASDAQ:GV) successfully convened the First Meeting of the Fourth Board of Directors. In strict compliance with the Business Corporations Act (Ontario, 1990), Securities Exchange Act of 1934 (USA), NASDAQ Listing Rules, and the relevant provisions of the Company's Bylaws, the meeting was conducted with legitimate convening procedures, qualified participants, and rigorous voting rules. All directors attended the meeting and unanimously adopted all core proposals, with the resolutions being legally valid, laying a solid institutiona

    11/4/25 9:30:00 AM ET
    $GV
    Other Consumer Services
    Real Estate

    Visionary Holdings Inc. 2025 Annual General Meeting Concludes Successfully: Completes Board Renewal, Anchors New Direction for Compliant Development

    TORONTO, Oct. 31, 2025 /PRNewswire/ -- Visionary Holdings Inc. (hereinafter referred to as the "Company"; a diversified enterprise registered in Ontario, Canada and listed on the Nasdaq Capital Market under the ticker symbol: GV) successfully held its 2025 Annual General Meeting (AGM) via Zoom video conference from 10:00 a.m. to 12:00 p.m. ET (UTC-4) on the same day. Chaired by Mr. Robert Jay LEES, the voting rights represented by attending shareholders and their proxies accounted for 97.79% of the company's total voting rights, far exceeding the quorum requirements stipulated in the Business Corporations Act (Ontario, 1990), Nasdaq Listing Rules, and the company's Articles of Association. T

    10/31/25 9:30:00 AM ET
    $GV
    Other Consumer Services
    Real Estate